HORIBA

HORIBA designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. From compact point of care solutions to high throughput laboratory systems these automated analysers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals. HORIBA expertise in in-vitro diagnostics is one of the most respected in haematology worldwide and contributes today to the healthcare of tomorrow. 

At the NHS Point of Care Conference, HORIBA will showcase its latest innovation in point‑of‑care haematology, designed to support rapid clinical decision‑making and antimicrobial resistance (AMR) management. Our newest solution combines Full Blood Count (FBC) 5‑part differential with CRP testing in a single, compact system, delivering fast, reliable results at the point of need. With a quick turnaround time and minimal sample volume requirements, it is particularly well suited to urgent care, community settings and small or vulnerable patient populations. By providing clinically actionable information during the patient encounter, the system supports timely treatment decisions, improved patient pathways and more effective antibiotic stewardship. HORIBA’s point‑of‑care solution enables healthcare professionals to deliver high‑quality diagnostics wherever care is needed, helping bridge the gap between laboratory accuracy and frontline clinical environments.